Shared on 03 Nov 25
Analysts have slightly increased their price target for Inogen to $13.00 per share. This change reflects modest adjustments to profit margin forecasts and discount rates in their updated models.
Shared on 20 Oct 25
Home And Outpatient Respiratory Care Will Expand Market Opportunities
Analysts have reaffirmed their price target for Inogen at $13.00, citing stable outlooks with only minor adjustments to key financial metrics. What's in the News Inogen issued new earnings guidance for the third quarter of 2025, projecting revenue between $91 million and $93 million.
Shared on 05 Oct 25
Fair value Increased 18%Home And Outpatient Respiratory Care Will Expand Market Opportunities
Analysts have raised their price target for Inogen from $11.00 to $13.00, citing updated projections of slightly stronger revenue growth and reduced discount rates as key contributors to the increased valuation. What's in the News Inogen, Inc.
Shared on 10 Aug 25
Fair value Decreased 5.71%Home And Outpatient Respiratory Care Will Expand Market Opportunities
Despite an upward revision in revenue growth forecasts and a lower future P/E, the analyst consensus price target for Inogen has decreased from $11.67 to $11.00, indicating increased caution around the company’s fair value. What's in the News Inogen expects third quarter 2025 revenue of $91–93 million (~4% YoY growth) and full-year 2025 revenue of $354–357 million (~6% YoY growth).
Shared on 01 May 25
Fair value Increased 38%Yuwell Collaboration Will Open Chinese Respiratory Market
Shared on 24 Apr 25
Fair value Decreased 14%Yuwell Collaboration Will Open Chinese Respiratory Market
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
Fair value Decreased 16%Yuwell Collaboration Will Open Chinese Respiratory Market
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Increased 18%